Curated Resources — Follow-up care timeline for Avelumab-related Merkel Cell Carcinoma

Below is a working bibliography of trusted health, pharmacovigilance, and legal-analysis sources, compiled for open research.

Recommended deep-dive

Follow-up care timeline for Avelumab-related Merkel Cell Carcinoma — Background & Analysis — detailed background and analysis.


U.S. Food and Drug Administration (FDA)

Reference: U.S. Food and Drug Administration (FDA)

Authoritative source for clinical, regulatory, and public-health background reading.

Centers for Disease Control and Prevention (CDC)

Reference: Centers for Disease Control and Prevention (CDC)

Authoritative source for clinical, regulatory, and public-health background reading.